The value of high-field MRI (3 T) in the assessment of sellar lesions

European Journal of Radiology

Volumn 54, Issue 3, 2005, Pages 327-334

  Pinker, K ^a   Ba Ssalamah, A ^a   Wolfsberger, S ^a   Mlynarik, V ^a   Knosp, E ^a   Trattnig, S ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

High field; High resolution; Magnetic resonance imaging; Pituitary adenoma; Sellar lesions

Indexed keywords

SELLAR LESIONS; SELLAR PATHOLOGIES; SURGICAL PLANNING;

DIAGNOSIS; HISTOLOGY; IMAGE RECONSTRUCTION; MAGNETIZATION; MEDICAL IMAGING; PATHOLOGY; PATIENT MONITORING; SENSITIVITY ANALYSIS; TUMORS;

MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIUM; DOPAMINE RECEPTOR BLOCKING AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CAVERNOUS SINUS; CENTRAL NERVOUS SYSTEM METASTASIS; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CLINICAL TRIAL; CRANIAL NERVE; DIAGNOSTIC ACCURACY; DRUG SAFETY; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; IMAGE DISPLAY; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MENINGIOMA; MICROADENOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PEROPERATIVE CARE; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; PROLACTINOMA; RADIATION FIELD; RADIOFREQUENCY; RANK SUM TEST; RATHKE CLEFT CYST; SARCOIDOSIS; SELLA TURCICA; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; STANDARD; STRENGTH; THICKNESS; THREE DIMENSIONAL IMAGING; TISSUE SLICE; TREATMENT PLANNING;

ADENOMA; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM INVASIVENESS; PITUITARY NEOPLASMS; SELLA TURCICA; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC;

EID: 19344376295     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2004.08.006     Document Type: Article

References (25)

1. S. Trattnig, A. Ba-Ssalamah, and I.M. Nöbauer-Huhmann MR contrast agent at high field MRI (3 T) Top Magn Reson Imaging 14 2003 365 375
2. I.M. Nöbauer-Huhmann, A. Ba-Ssalamah, and V. Mlynarik Magnetic resonance imaging contrast enhancement of brain tumors at 3 Tesla versus 1.5 Tesla Invest Radiol 37 2002 114 119
3. P. Novak, V. Novak, and A. Kangarlu High resolution MRI of the brainstem at 8 T J Comput Assist Tomogr 25 2001 242 246
4. J.W. Pan, J.T. Vaughan, and R.I. Kuzniecky High resolution neuroimaging at 4.1 T Magn Reson Imaging 13 1995 915 921
5. A. Ba-Ssalamah, I.M. Nöbauer-Huhmann, and K. Pinker Effect of contrast dose and fled-strength in the magnetic resonance detection of brain metastasis Invest Radiol 38 7 2003 415 422
6. G. Daita, Y. Yonemasu, and H. Nakai Cavernous sinus invasion by pituitary adenomas-relationship between magnetic resonance findings and histological verified dural invasion Neurol Med Chir (Tokyo) 35 1994 17 21
7. G. Scotti, C.Y. Yu, and W.P. Dillon MR Imaging of the cavernous sinus involvement by pituitary adenomas Radiographics 9 1988 587 598
8. D.L. Daniels, P. Pech, and L. Mark Magnetic resonance imaging of the cavernous sinus Am J Roentgenol 144 1985 1009 1014
9. S. Wolfsberger, A. Ba-Ssalamah, and K. Pinker Application of 3 T magnetic resonance imaging for diagnosis and surgery of sellar lesions Neurosurgery 100 2004 278 286
10. M. Barth, J.R. Reichenbach, and R. Venkatesan High resolution, multiple gradient echo functional MRI at 1.5 T Magn Reson Imaging 17 1999 321 329
11. B.P. Meij, M.B. Lopes, and D.B. Ellegala The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery J Neurosurg 96 2002 195 208
12. P.L. Reilly A.M. Landolt M.L. Vance P.L. Reilly Prolactinomas: Surgical Results and Prognosis 1996 Pituitary Adenomas New York, Churchill Livingston 363 376
13. V. Lefournier, M. Martinie, and A. Vasdev Accuracy of bilateral petrosal or cavernous sinus sampling in predicting the lateralization of Cushing's disease pituitary microadenoma: influence of catheter position and anatomy of venous drainage J Clin Endocrinol Metab 88 2003 196 203
14. M.E. Mollitch Medical therapy of pituitary tumors K. Thapar K.T. Kovacs B.W. Scheiterhauer Diagnosis and Management of Pituitary Tumors 2001 Humana Press Totawa, NJ 247 267
15. T. Brue, I. Pellegrini, and A. Priou Prolactinomas and resistence to dopamine agonists Horm Res 38 1992 4 89
16. Y. Kanou, K. Arita, and K. Kurisu Clinical implications of dynamic MRI for pituitary adenomas: clinical and histologic analysis J Clin Neurosci 9 6 2002 659 663
17. C.S. Zee, J.L. Go, and P.E. Kimm Imaging of the pituitary and the parasellar region Neurosurg Clin N Am 14 1 2003 55 80
18. E. Knosp, K. Kitz, and E. Steiner Pituitary adenomas with parasellar invasion Acta Neurochir Suppl (Wien) 53 1991 65 71
19. K. Thapar, and Laws Jr. Pituitary surgery K. Thapar K. Kovacs B.W. Scheitauer Diagnosis and Management of Pituitary Tumors 2001 Humana Press Totawa, NJ 225 246
20. E. Knosp, E. Steiner, and K. Kitz Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings Neurosurgery 33 1993 610 617
21. J.L. Dietemann, P. Kehrli, and C. Maillot Is there a dural wall between the cavernous sinus and the pituitary fossa? Anatomical and MRI findings Neuroradiology 40 1998 627
22. J.P. Cottier, C. Destrieux, and L. Brunerau Cavernous sinus invasion by pituitary adenoma: MR imaging Radiology 215 2000 463 469
23. E. Steiner, H. Imhof, and E. Knosp Gd-DTPA enhanced high resolution MR imaging of pituitary adenomas Radiographics 9 1989 587 598
24. F. Umansky, and H. Nathan The lateral wall of the cavernous sinus. With special reference to the related to it J Neurosurg 56 1982 228 234
25. Y. Korogi, M. Takahashi, and Y. Sakamoto Cavernous sinus: correlation between anatomic and dynamic gadolinium-enhanced MR imaging findings Radiology 180 1991 235 237